ERIC Recommendations

Immunoglobulin Gene Sequence Analysis in Chronic Lymphocytic Leukemia: Updated ERIC recommendations (Rosenquist, Leukemia 2017)

ERIC recommendations for IGHV gene mutational analysis in CLL for problematic cases (Langerak, Leukemia 2011)

ERIC recommendations for IGHV gene mutational analysis in CLL (Ghia, Leukemia 2007)

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study (Rawstron, Leukemia, 2016)

Improving efficiency and sensitivity: ERIC update on the international harmonised approach for flow cytometric residual disease monitoring in CLL (Rawstron, Leukemia, 2013)

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia (Rawstron, Leukemia 2007)

ERIC recommendations on TP53 mutation analysis in CLL – Update on methodological approaches and results interpretation (Pospisilova, Leukemia 2018)

ERIC recommendations on TP53 mutation analysis in Chronic Lymphocytic Leukemia (Pospisilova, Leukemia 2012)

ERIC/EBMT recommendations on allogeneic stem cell transplantation in CLL (Montserrat, Dreger, Current Hematologic Malignancy Reports 2015)